VEGFA and neoplasm: To assess the clinical relevance of VEGFA+ TANs, gene set variation analysis (GSVA) was employed, demonstrating significant enrichment of these TANs in tumor samples over normal tissues within the GSE63514 database (Fig. 4d, e).